Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Proto-oncogene proteins c-akt inhibitors(Proto-oncogene proteins c-akt inhibitors), RPS6KB1 inhibitors(Ribosomal protein S6 kinase beta-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H20ClN3 |
InChIKeyLZMOSYUFVYJEPY-UHFFFAOYSA-N |
CAS Registry857531-00-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 09 May 2010 |